The use of nanotechnology for treatment of multidrug resistant ovarian cancer cells

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• European Journal of Pharmaceutics and Biopharmaceutics.

  2020cited by this paper
• Amorphous silica nanoparticles induce tumorigenesis via regulating ATP5H/SOD1-related oxidative stress, oxidative phosphorylation and EIF4G2/PABPC1-associated translational initiation

  2019cited by this paper
• Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement

  2018cited by this paper
• Establishment of patient-derived tumor spheroids for non-small cell lung cancer

  2018cited by this paper
• PARP Inhibitors for the Treatment of Ovarian Cancer.

  2018cited by this paper
• Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo

  2018cited by this paper
• Cathepsin D non-proteolytically induces proliferation and migration in human omental microvascular endothelial cells via activation of the ERK1/2 and PI3K/AKT pathways.

  2018cited by this paper
• The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis

  2018cited by this paper
• Ovarian cancer: Novel molecular aspects for clinical assessment.

  2017cited by this paper
• Biomedical applications of nanodiamond (Review)

  2017influential reference
• Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.

  2017cited by this paper
• The new era of nanotechnology, an alternative to change cancer treatment

  2017cited by this paper
• Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling.

  2017cited by this paper
• Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.

  2017cited by this paper
• Ovarian cancer in pregnancy.

  2017cited by this paper
• Co-delivery strategies to overcome multidrug resistance in ovarian cancer.

  2017influential reference
• In‐vitro cytotoxicity and combination effects of the docetaxel‐conjugated and doxorubicin‐conjugated poly(lactic acid)‐poly(ethylene glycol)‐folate‐based polymeric micelles in human ovarian cancer cells

  2017cited by this paper
• Gene set-based analysis of mucinous ovarian carcinoma.

  2017cited by this paper
• Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice

  2017cited by this paper
• Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers.

  2017cited by this paper
• Challenges and strategies in anti-cancer nanomedicine development: An industry perspective.

  2017cited by this paper
• Cytotoxicity and cellular uptake of different sized gold nanoparticles in ovarian cancer cells

  2017cited by this paper
• Dynamic real-time in vivo confocal laser endomicroscopy of the fallopian tube during laparoscopy in the prevention of ovarian cancer.

  2017cited by this paper
• Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer.

  2017influential reference
• Biological Synthesis of Nanoparticles from Plants and Microorganisms.

  2016cited by this paper
• Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.

  2016cited by this paper
• Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

  2016cited by this paper
• Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters.

  2016cited by this paper
• Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications

  2016cited by this paper
• In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing.

  2016cited by this paper
• Composite Gel Polymer Electrolyte for Lithium Ion Batteries

  2016cited by this paper
• ABC transporters as mediators of drug resistance and contributors to cancer cell biology.

  2016cited by this paper
• Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures.

  2016cited by this paper
• Challenges in the size analysis of a silica nanoparticle mixture as candidate certified reference material

  2016cited by this paper
• Size and ζ-Potential Measurement of Silica Nanoparticles in Serum Using Tunable Resistive Pulse Sensing.

  2016cited by this paper
• Low-grade serous ovarian cancer: A review.

  2016cited by this paper
• pH sensitive nano layered double hydroxides reduce the hematotoxicity and enhance the anticancer efficacy of etoposide on non-small cell lung cancer.

  2016cited by this paper
• Contribution of age to clinical trial enrollment and tolerance with ovarian cancer.

  2016cited by this paper
• Fluorescent Nanodiamond: A Versatile Tool for Long-Term Cell Tracking, Super-Resolution Imaging, and Nanoscale Temperature Sensing.

  2016cited by this paper
• Chemoresistance and targeted therapies in ovarian and endometrial cancers

  2016cited by this paper
• DUSP1 induces paclitaxel resistance through the regulation of p-glycoprotein expression in human ovarian cancer cells.

  2016cited by this paper
• Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer.

  2016cited by this paper
• Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

  2015cited by this paper
• Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian Cancer.

  2015cited by this paper
• Cancer active targeting by nanoparticles: a comprehensive review of literature

  2015cited by this paper
• Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells

  2015cited by this paper
• Biomedical Applications of Nanodiamonds: An Overview.

  2015cited by this paper
• Green synthesis of nanoparticles and its potential application

  2015cited by this paper
• Whole–genome characterization of chemoresistant ovarian cancer

  2015cited by this paper
• "Platinum resistant" ovarian cancer: what is it, who to treat and how to measure benefit?

  2014cited by this paper
• Tumorgrafts as In Vivo Surrogates for Women with Ovarian Cancer

  2014cited by this paper
• Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells

  2014cited by this paper
• Monodisperse FePt Nanoparticles and Ferromagnetic FePt Nanocrystal Superlattices

  2014cited by this paper
• Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer

  2014cited by this paper
• Nanoscale Metal–Organic Frameworks for the Co-Delivery of Cisplatin and Pooled siRNAs to Enhance Therapeutic Efficacy in Drug-Resistant Ovarian Cancer Cells

  2014cited by this paper
• Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics.

  2014cited by this paper
• The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.

  2014cited by this paper
• Nanodiamond–Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells

  2014cited by this paper
• A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer.

  2014cited by this paper
• D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.

  2014cited by this paper
• Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.

  2014cited by this paper
• Nanodiamond-mediated impairment of nucleolar activity is accompanied by oxidative stress and DNMT2 upregulation in human cervical carcinoma cells.

  2014cited by this paper
• Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.

  2013cited by this paper
• An international assessment of ovarian cancer incidence and mortality.

  2013cited by this paper
• Biomedical applications of nanodiamonds in imaging and therapy.

  2013cited by this paper
• Ovarian Cancer - A Clinical and Translational Update

  2013cited by this paper
• ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.

  2013cited by this paper
• Lipid-functionalized Dextran Nanosystems to Overcome Multidrug Resistance in Cancer: A Pilot Study

  2013cited by this paper
• NANOTECHNOLOGY IN CANCER THERAPY

  2013cited by this paper
• Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

  2013cited by this paper
• Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

  2013cited by this paper
• Gold-doxorubicin nanoconjugates for overcoming multidrug resistance.

  2012cited by this paper
• Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors

  2012cited by this paper
• Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.

  2012cited by this paper
• Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles.

  2012cited by this paper
• Nanocarriers for ovarian cancer active drug targeting

  2012cited by this paper
• Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology

  2012cited by this paper
• Diamond as a nanomedical agent for versatile applications in drug delivery, imaging, and sensing

  2012cited by this paper
• A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond

  2012cited by this paper
• Green synthesized ZnO nanoparticles against bacterial and fungal pathogens

  2012cited by this paper
• MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis.

  2011cited by this paper
• Rethinking ovarian cancer: recommendations for improving outcomes

  2011cited by this paper
• Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells.

  2011cited by this paper
• Green synthesis of metal nanoparticles using plants

  2011influential reference
• Doxorubicin pathways: pharmacodynamics and adverse effects

  2011cited by this paper
• Toxicity of silver nanoparticles in human macrophages: uptake, intracellular distribution and cellular responses

  2011cited by this paper
• Nanomaterials in controlled drug release

  2011cited by this paper
• Worldwide burden of cervical cancer in 2008.

  2011cited by this paper
• Synthesis of highly stable dispersions of nanosized copper particles using L-ascorbic acid

  2011cited by this paper
• Green synthesis of zinc oxide nanoparticles by aloe barbadensis miller leaf extract: Structure and optical properties

  2011cited by this paper
• Fenton-treated functionalized diamond nanoparticles as gene delivery system.

  2010cited by this paper
• Augmentation of Therapeutic Efficacy in Drug-Resistant Tumor Models Using Ceramide Coadministration in Temporal-Controlled Polymer-Blend Nanoparticle Delivery Systems

  2010cited by this paper
• Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.

  2010cited by this paper
• Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.

  2010cited by this paper
• Size-dependent reactivity of diamond nanoparticles.

  2010cited by this paper
• Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma.

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cited by this paper
• OVA1 test for preoperative assessment of ovarian cancer

  2010cited by this paper
• Genotoxicity and cytotoxicity of zinc oxide and titanium dioxide in HEp-2 cells.

  2010cited by this paper
• Nanodiamond-mediated delivery of water-insoluble therapeutics.

  2009cited by this paper

• No citing papers are available for this paper.